ROCKVILLE, Maryland, March 11, 2024 (GLOBE NEWSWIRE) — Theriva™ Biologics (NYSE American: TOVX), empresa diversificada de fase clínica que investiga […]
SEATTLE, March 11, 2024 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company […]
Record Fourth Quarter and Full Year Revenue Full-year 2023 Adjusted EBITDA1 exceeded upper range of prior guidance Cash and cash equivalents, short and […]